BBLG News and Press, Bone Biologics Corp From 12/12/22

This article is about penny stocks under $1; they can be purchased for pennies, but does that mean they’re worth it? You can decide for yourself based on your trading strategy. This niche within the stock market today has grown in popularity over the last few months. Due to the 2022 st...

Bone Biologics Corporation (NASDAQ: BBLG) , a developer of orthobiologic products for spine fusion markets, today issued the following letter to stockholders from its President and Chief Executive Officer, Jeffrey Frelick. To My Fellow Stockholders: I am delighted to...

WallachBeth Capital Announces Closing of Bone Biologics $5,100,000 Underwritten Public Offering PR Newswire JERSEY CITY, N.J. , Oct. 13, 2022 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution servic...

Bone Biologics Corporation (NASDAQ: BBLG) , a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced underwritten public offering of units of securities for total gross proceeds of $5,100,000, before deducting underwriti...

Reissuing release to remove "million" after "$5,100,000" in the headline and first sentence of the text. The updated release reads: BONE BIOLOGICS PRICES $5,100,000 UNDERWRITTEN PUBLIC OFFERING Bone Biologics Corporation (NASDAQ: BBLG) , a developer of orthob...

WallachBeth Capital Announces Pricing of Bone Biologics $5,100,000 Underwritten Public Offering PR Newswire JERSEY CITY, N.J. , Oct. 7, 2022 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution service...

Orthobiologic products company Bone Biologics ( NASDAQ: BBLG ) priced an underwritten public offering of 3.8M units of securities at $1.35 per unit. The total gross proceeds stood at $5.1M, before deducting underwriting discounts and commissions and other estimated of...

Bone Biologics Corporation (NASDAQ: BBLG) , a developer of orthobiologic products for spine fusion markets, announces the pricing of an underwritten public offering of 3,777,778 units of securities at an offering price of $1.35 per unit, for total gross proceeds of $5,100,00...

Gainers: Bone Biologics (BBLG) +13%. Akero Therapeutics AKRO +10%. Biotricity (BTCY) +9%. Jasper Therapeutics (JSPR) +7%. Burning Rock Biotech (BNR) +6%. Losers: AC Immune ACIU -17%. Arcellx ACLX -17%. SOPHiA GENETICS (SOPH) -16%. AirSculpt Te...

Gainers: Nkarta NKTX +111%. ERYTECH Pharma ERYP +44%. Rubius Therapeutics RUBY +34%. Redbox Entertainment RDBX +32%. Sky Harbour Group (SKYH) +28%. Sunshine Biopharma SBFM +26%. Cabaletta Bio (CABA) +23%. Cango CANG +22%. WISeKey International (WKEY) +19%. Veru V...